IBL International Overview

  • Founded
  • 1983
  • Status
  • Acquired/​Merged
  • Employees
  • 82
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $35.8M
Latest Deal Amount

IBL International General Information


Producer of immunoassays and antibodies. The company focuses on assays for rare indications, including immunoassays for the measurement of neurodegenerative diseases, neonatal screening and the diagnosis of stress parameters and steroid hormones in saliva.

Contact Information

Ownership Status
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Other Devices and Supplies
Other Healthcare
Other Pharmaceuticals and Biotechnology
Primary Office
  • Flughafenstraße 52a
  • 22335 Hamburg
  • Germany
+49 040 0000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

IBL International Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 30-Aug-2014 $35.8M 000.00 Completed Generating Revenue
4. Grant 16-Aug-2012 Completed Product Development
3. Grant 01-Jan-2009 Completed Product Development
2. Later Stage VC Completed
1. Later Stage VC 30-Sep-2008 Completed Product Development
To view IBL International’s complete valuation and funding history, request access »

IBL International Executive Team (6)

Name Title Board Seat Contact Info
Dirk Bottcher Head, Finance
Gerd Neubert Head, Sales
You’re viewing 2 of 6 executive team members. Get the full list »

IBL International Board Members (2)

Name Representing Role Since
Willem van Hulsenbeek Self Chairman 000 0000
You’re viewing 1 of 2 board members. Get the full list »

IBL International Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

IBL International Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Oost NL Venture Capital Minority 000 0000 000000 0
Wadinko Venture Capital Majority 000 0000 000000 0
To view IBL International’s complete investors history, request access »